IL6 and cancer: Immunohistochemical analyses of serial tumour sections revealed that, whereas IL6-expressing regions largely overlapped with those for cytokeratin 6, a 4T1 cancer cell marker, they did not significantly overlap with those for CD45, an immune cell marker (Fig. 7a).